FDA urged to follow science, not hope, in quest for COVID-19 cures
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
Former FDA Commissioner Margaret Hamburg and FDA’s former Acting Chief Scientist Luciana Borio Thursday cautioned the agency to put science ahead of hope when responding to the COVID-19 pandemic.
They spoke with BioCentury following public statements from President Donald Trump calling for widespread use of unapproved drugs under compassionate use to treat COVID-19.
“The magnitude and urgency of the threat creates tremendous pressure to accelerate product development and availability, even when these candidates remain unproven with respect to safety and efficacy,” Hamburg told BioCentury. “However, we cannot allow the desire to do whatever we can in the face of a tragic pandemic to divert us from making science-based